# Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

> **NCT04243954** · PHASE2 · COMPLETED · sponsor: **Fujian Cancer Hospital** · enrollment: 95 (actual)

## Conditions studied

- Cancer Pain

## Interventions

- **DRUG:** PCA IV Hydromorphone (continuous dose = 0)
- **DRUG:** PCA IV Hydromorphone (continuous dose ≠ 0)
- **DRUG:** Oral morphine

## Key facts

- **NCT ID:** NCT04243954
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-10
- **Primary completion:** 2020-10-21
- **Final completion:** 2020-11-21
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243954, "Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04243954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*